Copyright
©2007 Baishideng Publishing Group Inc.
World J Gastroenterol. Dec 14, 2007; 13(46): 6150-6155
Published online Dec 14, 2007. doi: 10.3748/wjg.v13.i46.6150
Published online Dec 14, 2007. doi: 10.3748/wjg.v13.i46.6150
Table 4 Efficacy at 2 yr against virological suppression (PCR negative) at 24 wk in HBeAg positive and negative individuals in the Globe study
Yr 2 outcome | Probability (%) | |
HBeAg positive | HBeAg seroconversion | 45 |
ALT normalization | 79 | |
HBV DNA non-detectable by PCR | 77 | |
HBeAg negative | ALT normalization | 77 |
HBV DNA non-detectable by PCR | 74 |
- Citation: Amarapurkar DN. Telbivudine: A new treatment for chronic hepatitis B. World J Gastroenterol 2007; 13(46): 6150-6155
- URL: https://www.wjgnet.com/1007-9327/full/v13/i46/6150.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i46.6150